Pfizer Stock Has Risen 11% In A Month But Will The Gains Continue?

The stock price of Pfizer has seen an 11% rise over the last twenty-one trading days, and most of the gains have come over the last ten trading days, after the company reported strong Q2 results, and revised its full-year outlook upward. Note that such a move for PFE stock is uncommon, and it has…

About the Author

has written 23519 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com